Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 4/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | RXRA | P19793 | 1/20 | 0.42 |
| ▸ | RXRB | P28702 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 5/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5051394 | 0.90 | IDO1 (0.44) | IDO1HTR2ATAAR1APPRXRA | |
| SCHEMBL8038501 | 0.88 | IDO1 (0.45) | IDO1HTR2ATAAR1APPRXRA | |
| SCHEMBL4938371 | 0.83 | IDO1 (0.48) | IDO1HTR2ATAAR1APPRXRA | |
| SCHEMBL9849327 | 0.82 | TRPA1 (0.39) | IDO1CA2CA9 | |
| SCHEMBL742829 | 0.79 | ALDH1A1 (0.46) | APPMAOBKMT2ACA2CA9 | |
| SCHEMBL8855401 | 0.79 | IDO1 (0.50) | IDO1TAAR1APPKMT2ACA2 | |
| SCHEMBL4408254 | 0.78 | TAAR1 (0.50) | IDO1HTR2ATAAR1MAOBKMT2A | |
| SCHEMBL4412388 | 0.77 | IDO1 (0.50) | IDO1MAOB | |
| SCHEMBL6020749 | 0.77 | CA2 (0.32) | CA2CA9 | |
| SCHEMBL17061042 | 0.77 | CYP3A4 (0.52) | IDO1APPRXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118006052-A | Environment-friendly flame-retardant polystyrene composite material and preparation method thereof | 连云港传奇阻燃科技有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-110229108-B | Styrene-bis-phenanthroimidazole derivative and preparation method and application thereof | 广东工业大学 | 2022-06-14 | — | — | CN | claimed |
| CN-118006052-A | Environment-friendly flame-retardant polystyrene composite material and preparation method thereof | 连云港传奇阻燃科技有限公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-117980292-A | Substituted pyridone compounds for the treatment of orthomyxoviral infections | 诺华股份有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-117279898-A | Antibacterial compounds | 布莱克史密斯医药公司 | 2023-12-22 | — | — | CN | disclosed |
| CN-116041392-A | Compound containing phosphate group, preparation method and application thereof | 中国科学院长春应用化学研究所 | 2023-05-02 | — | — | CN | disclosed |
| CN-110229108-B | Styrene-bis-phenanthroimidazole derivative and preparation method and application thereof | 广东工业大学 | 2022-06-14 | — | — | CN | disclosed |
| CN-109705041-A | A kind of phenanthro- glyoxaline compound of triphenylamine substitution-modified by vinyl and preparation method thereof and application as electroluminescent device | 广东工业大学 | 2019-05-03 | — | — | CN | disclosed |
| CN-107434814-B | Modified conjugated polymer and its preparation method and application | 中国科学院化学研究所 | 2019-05-03 | — | — | CN | disclosed |
| CN-107098818-A | Aromatic compound and organic light emitting diode comprising same | 郑建鸿 | 2017-08-29 | — | — | CN | disclosed |
| US-20120328518-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN INHIBITORS | PIRAMAL IMAGING SA (CH) | 2012-12-27 | — | — | US | disclosed |
| US-20080139778-A1 | Resin and article molded therefrom | TAKANISHI KEIJIRO | 2008-06-12 | — | — | US | disclosed |
| US-20060287464-A1 | Resin and article molded therefrom | TORAY INDUSTRIES, INC. (JP) | 2006-12-21 | — | — | US | disclosed |
| EP-1640405-A1 | RESIN AND ARTICLE MOLDED THEREFROM | TORAY INDUSTRIES, INC. (JP) | 2006-03-29 | — | — | EP | disclosed |
| US-6750313-B2 | HIGH REFRACTIVE INDEX AND LOW DISPERSION CHARACTERISTICS; OPTICAL LENSES, FILMS, DISCS; POLYCARBONATE RESIN CONTAINING A PHOSPHONIC ACID GROUP | TORAY INDUSTRIES, INC. (JP) | 2004-06-15 | — | — | US | disclosed |
| US-20030157367-A1 | Blue light-emitting polymer containing 9, 10-diphenylanthracene moiety and electroluminescent device using the same | SK CORPORATION | 2003-08-21 | — | — | US | disclosed |
| WO-2003040255-A1 | BLUE LIGHT-EMITTING POLYMER CONTAINING 9,10-DIPHENYLANTHRACENE MOIETY AND ELECTROLUMINESCENT DEVICE USING THE SAME | SK CORPORATION (KR) | 2003-05-15 | — | — | WO | disclosed |
| US-20030013836-A1 | Resin composition and articles molded therefrom | TORAY INDUSTRIES, INC., A CORPORATION OF JAPAN (JP) | 2003-01-16 | — | — | US | disclosed |
| EP-1270646-A1 | RESIN COMPOSITION AND ARTICLES MOLDED THEREFROM | TORAY INDUSTRIES, INC. (JP) | 2003-01-02 | — | — | EP | disclosed |
| CN-1053793-A | Use the disease that benzylphosphonic acid derivatives for treatment is caused by virus | HOECHST AG (DE) | 1991-08-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120328518-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN INHIBITORS | KLK3, FOLH1, ACP3 | IDO1 4708/4885HTR2A 4716/4885TAAR1 3830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.